Amedisys Announces First Quarter Earnings Release and Conference Call Date
April 21 2015 - 12:00PM
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health
and hospice care companies, announced today that it will host a
conference call to discuss results for the first quarter ended
March 31, 2015 on Wednesday, April 29, 2015 at 11:00 a.m. Eastern
Time (10:00 a.m. Central Time). The Company will issue its
quarterly earnings release prior to hosting the conference call.
To participate on the conference call, please call a few minutes
before 11:00 a.m. ET to either (877) 512-9171 (Toll free) or (815)
573-0979, use conference ID #30632022. A replay of the
conference call will be available through May 29, 2015. The
replay dial in number is (855) 859-2056 (Toll free) or (404)
537-3406 (Toll) and use conference ID #30632022.
A live webcast of the call will be accessible through our
website on our Investor Relations section at the following web
address: http://investors.amedisys.com.
Amedisys, Inc. (the "Company") is headquartered in Baton Rouge,
Louisiana and our common stock trades on the NASDAQ Global Select
Market under the symbol "AMED".
About Amedisys:
Amedisys, Inc. (Nasdaq:AMED) is a "health care at home" company
delivering personalized home health and hospice care to more than
360,000 patients each year. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
recovery and rehabilitation after an operation or injury, care
focused on empowering them to manage a chronic disease, palliative
care for those with a terminal illness, or hospice care at the end
of life. For more information about Amedisys, please visit:
http://www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, analyst presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. We will also use our website to expedite
public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing
with the Securities and Exchange Commission ("SEC") disclosing the
same information. In addition, we make available on the Investor
Relations subpage of our website (under the link "SEC filings")
free of charge our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, ownership reports on
Forms 3, 4 and 5 and any amendments to those reports as soon as
practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our
Code of Ethical Business Conduct and the charters for the Audit,
Compensation, Nominating and Corporate Governance, Quality of Care
and Compliance and Ethics Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
CONTACT: Amedisys, Inc.
David Castille
Managing Director, Finance and Assistant Treasurer
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024